A functional T-cell receptor signaling pathway is required for p95vav activity
暂无分享,去创建一个
J. Wu | A. Weiss | S. Katzav | Jun Wu | Shulamit Katzav | Andarthur Weiss
[1] M. Barbacid,et al. Defective T-cell receptor signalling and positive selection of Vav-deficient CD4+CDS+thymocytes , 1995, Nature.
[2] F. Alt,et al. Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene , 1995, Nature.
[3] K. Rajewsky,et al. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav , 1995, Nature.
[4] G. Dreyfuss,et al. Association of the vav proto-oncogene product with poly(rC)-specific RNA-binding proteins , 1995, Molecular and cellular biology.
[5] S. Shoelson,et al. Interaction of Shc with Grb2 regulates association of Grb2 with mSOS , 1995, Molecular and cellular biology.
[6] M. Barbacid,et al. The vav proto‐oncogene is required early in embryogenesis but not for hematopoietic development in vitro. , 1995, The EMBO journal.
[7] J. Norman,et al. The small GTPases Rac and Rho as regulators of secretion in mast cells , 1995, Current Biology.
[8] A. Weiss,et al. The protein tyrosine kinase ZAP-70 can associate with the SH2 domain of proto-Vav. , 1994, The Journal of biological chemistry.
[9] C. Der,et al. Dbl and Vav mediate transformation via mitogen-activated protein kinase pathways that are distinct from those activated by oncogenic Ras , 1994, Molecular and cellular biology.
[10] R. Bram,et al. Calcium signalling in T cells stimulated by a cyclophilin B-binding protein , 1994, Nature.
[11] O. Hobert,et al. Novel signaling pathway suggested by SH3 domain-mediated p95vav/heterogeneous ribonucleoprotein K interaction. , 1994, The Journal of biological chemistry.
[12] M. Barbacid,et al. Vav cooperates with Ras to transform rodent fibroblasts but is not a Ras GDP/GTP exchange factor. , 1994, Oncogene.
[13] J. Schlessinger,et al. GRB2 and phospholipase C-gamma 1 associate with a 36- to 38-kilodalton phosphotyrosine protein after T-cell receptor stimulation , 1994, Molecular and cellular biology.
[14] A. Wittinghofer,et al. Direct stimulation of Vav guanine nucleotide exchange activity for Ras by phorbol esters and diglycerides , 1994, Molecular and cellular biology.
[15] A. Nel,et al. The T-cell antigen receptor utilizes Lck, Raf-1, and MEK-1 for activating mitogen-activated protein kinase. Evidence for the existence of a second protein kinase C-dependent pathway in an Lck-negative Jurkat cell mutant. , 1994, The Journal of biological chemistry.
[16] M. Barbacid,et al. Zinc finger domains and phorbol ester pharmacophore. Analysis of binding to mutated form of protein kinase C zeta and the vav and c-raf proto-oncogene products. , 1994, The Journal of biological chemistry.
[17] A. Altman,et al. Tyrosine phosphorylation and activation of Vav GTP/GDP exchange activity in antigen receptor-triggered B cells. , 1994, Journal of immunology.
[18] A. Weiss,et al. Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases. , 1994, Science.
[19] A. Wittinghofer,et al. Activation of Ras in vitro and in intact fibroblasts by the Vav guanine nucleotide exchange protein , 1994, Molecular and cellular biology.
[20] Dan R. Littman,et al. Signal transduction by lymphocyte antigen receptors , 1994, Cell.
[21] S. Aaronson,et al. Cellular transformation and guanine nucleotide exchange activity are catalyzed by a common domain on the dbl oncogene product. , 1994, The Journal of biological chemistry.
[22] G. Won,et al. Zinc Finger Domains and Phorbol Ester Pharmacophore , 1994 .
[23] Mark S. Boguski,et al. Proteins regulating Ras and its relatives , 1993, Nature.
[24] D. Cantrell,et al. p21ras and calcineurin synergize to regulate the nuclear factor of activated T cells , 1993, The Journal of experimental medicine.
[25] L. Davis,et al. Raf‐1 is required for T cell IL2 production. , 1993, The EMBO journal.
[26] J. Thompson,et al. The PH domain: a common piece in the structural patchwork of signalling proteins. , 1993, Trends in biochemical sciences.
[27] W. Farrar,et al. Interleukin-2 induces tyrosine phosphorylation of the vav proto-oncogene product in human T cells: lack of requirement for the tyrosine kinase lck. , 1993, The Biochemical journal.
[28] J. Schlessinger,et al. How receptor tyrosine kinases activate Ras. , 1993, Trends in biochemical sciences.
[29] A. Altman,et al. Tyrosine kinase-stimulated guanine nucleotide exchange activity of Vav in T cell activation. , 1993, Science.
[30] A. Weiss,et al. CD45 specifically modulates binding of Lck to a phosphopeptide encompassing the negative regulatory tyrosine of Lck. , 1993, The EMBO journal.
[31] J. Downward,et al. p21ras mediates control of IL‐2 gene promoter function in T cell activation. , 1992, The EMBO journal.
[32] Arthur Weiss,et al. ZAP-70: A 70 kd protein-tyrosine kinase that associates with the TCR ζ chain , 1992, Cell.
[33] Arthur Weiss,et al. Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor , 1992, Cell.
[34] Anne J. Ridley,et al. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling , 1992, Cell.
[35] Anne J. Ridley,et al. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors , 1992, Cell.
[36] Amos Bairoch,et al. Proto-vav and gene expression , 1992, Nature.
[37] J. Downward,et al. Role of protein kinase C in T-cell antigen receptor regulation of p21ras: evidence that two p21ras regulatory pathways coexist in T cells , 1992, Molecular and cellular biology.
[38] G. Crabtree,et al. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation , 1992, Nature.
[39] E. A. O'neill,et al. FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin , 1992, Nature.
[40] M. Barbacid,et al. Tyrosine Phosphorylation of the vav Proto-Oncogene Product in Activated B Cells , 1992, Science.
[41] C. Klee,et al. Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[42] T. Lints,et al. The hematopoietically expressed vav proto-oncogene shares homology with the dbl GDP-GTP exchange factor, the bcr gene and a yeast gene (CDC24) involved in cytoskeletal organization. , 1992, Oncogene.
[43] M. Amiot,et al. Sequence requirements for induction of cytolysis by the T cell antigen Fc receptor ζ chain , 1992, Cell.
[44] M. Barbacid,et al. Product of vav proto-oncogene defines a new class of tyrosine protein kinase substrates , 1992, Nature.
[45] D. Birnbaum,et al. The products of the mcf-2 and vav proto-oncogenes and of the yeast gene cdc-24 share sequence similarities. , 1992, Oncogene.
[46] T Pawson,et al. SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. , 1991, Science.
[47] L. Bockenstedt,et al. Signaling via the inositol phospholipid pathway by T cell antigen receptor is limited by receptor number. , 1991, Journal of immunology.
[48] J. Cleveland,et al. Loss of the amino-terminal helix-loop-helix domain of the vav proto-oncogene activates its transforming potential , 1991, Molecular and cellular biology.
[49] R. Stancou,et al. A hemopoietic specific gene encoding a small GTP binding protein is overexpressed during T cell activation. , 1991, Biochemical and biophysical research communications.
[50] A. Weiss,et al. Tyrosine phosphatase CD45 is required for T-cell antigen receptor and CD2-mediated activation of a protein tyrosine kinase and interleukin 2 production. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[51] Arthur Weiss,et al. The cytoplasmic domain of the T cell receptor ζ chain is sufficient to couple to receptor-associated signal transduction pathways , 1991, Cell.
[52] M. Barbacid,et al. Mechanism of activation of the vav protooncogene. , 1991, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[53] G. Carpenter,et al. Increase of the catalytic activity of phospholipase C-gamma 1 by tyrosine phosphorylation. , 1990, Science.
[54] A. Weiss,et al. Stimulation of the phosphatidyl-inositol pathway can induce T-cell activation , 1990, Nature.
[55] G. Schieven,et al. Inhibition of tyrosine phosphorylation prevents T-cell receptor-mediated signal transduction. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[56] S. Nagata,et al. pEF-BOS, a powerful mammalian expression vector. , 1990, Nucleic acids research.
[57] P. Warne,et al. Stimulation of p21ras upon T-cell activation , 1990, Nature.
[58] A. Weiss,et al. Tyrosine phosphatase CD45 is essential for coupling T-cell antigen receptor to the phosphatidyl inositol pathway , 1990, Nature.
[59] A. Weiss,et al. Stimulation of the phosphatidylinositol pathway can induce T-cell activation. , 1990, Nature.
[60] G. Crabtree,et al. Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation. , 1989, Science.
[61] M. Goldsmith,et al. Function of a heterologous muscarinic receptor in T cell antigen receptor signal transduction mutants. , 1989, The Journal of biological chemistry.
[62] M. Barbacid,et al. vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells. , 1989, The EMBO journal.
[63] M. Goldsmith,et al. At least two non-antigen-binding molecules are required for signal transduction by the T-cell antigen receptor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[64] G. Crabtree,et al. Characterization of antigen receptor response elements within the interleukin-2 enhancer , 1988, Molecular and cellular biology.
[65] M. Goldsmith,et al. Isolation and characterization of a T-lymphocyte somatic mutant with altered signal transduction by the antigen receptor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[66] T. Mak,et al. Reconstitution of an active surface T3/T-cell antigen receptor by DNA transfer , 1985, Nature.
[67] A. Weiss,et al. Requirement for the coexpression of T3 and the T cell antigen receptor on a malignant human T cell line , 1984, The Journal of experimental medicine.